David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q4 2025 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −3,309−100.0% | Sold out | Holders |
| Q1 2025 | 3,309 | $202.5K | <0.1% | −296−8.2% | Reduced | Holders |
| Q4 2024 | 3,605 | $311.0K | <0.1% | +254+7.6% | Added | Holders |
| Q3 2024 | 3,351 | $385.6K | <0.1% | +323+10.7% | Added | Holders |
| Q2 2024 | 3,028 | $432.2K | <0.1% | +251+9.0% | Added | Holders |
| Q1 2024 | 2,777 | $346.7K | <0.1% | +138+5.2% | Added | Holders |
| Q4 2023 | 2,639 | $279.7K | <0.1% | −524−16.6% | Reduced | Holders |
| Q3 2023 | 3,163 | $281.6K | <0.1% | +145+4.8% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 1,509 | $238.9K | <0.1% | +1,509 | New | Holders |